title: Responding to a rebuttal letter concerning the BERVOLT study.
authors.affiliation: The Soroka University Medical Center, Ben Gurion University of the Negev, Beer Sheva, Israel. tomchook@gmail.com.
authors.forename: Tom
authors.initials: T
authors.lastname: Kornhauser
authors.affiliation: Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Adiel
authors.initials: A
authors.lastname: Barak
mesh_terms: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab; D005500:Follow-Up Studies; D006801:Humans; D008269:Macular Edema; D012170:Retinal Vein Occlusion
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab
keywords: Bevacizumab; Branch retinal vein occlusion; Central retinal vein occlusion; Retinal vein occlusion